49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

26 trials found

diseases per page:

Showing 1 to 10 of 26 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-002758-62-IT (EUCTR)	14/10/2014	31/03/2014	Long-term safety and tolerability study of ataciceptin patients with Systemic Lupus Erythematosus wh ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	213	Phase 2	United States;Philippines;Spain;Ukraine;Chile;Russian Federation;United Kingdom;Italy;Czech Republic ...
2	EUCTR2013-002758-62-DE (EUCTR)	18/08/2014	13/03/2014	Long-term safety and tolerability study of ataciceptin patients with Systemic Lupus Erythematosus wh ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	213	Phase 2	United States;Philippines;Spain;Ukraine;Russian Federation;Chile;United Kingdom;Italy;Czech Republic ...
3	NCT02070978 (ClinicalTrials.gov)	July 29, 2014	21/2/2014	Long-term Safety and Tolerability of Atacicept(Long-term Follow-Up of Participant Who Participated i ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Lupus Erythematosus, Systemic	Drug: Atacicept 75 mg;Drug: Atacicept 150 mg	EMD Serono	NULL	Terminated	18 Years	N/A	All	253	Phase 2	United States;Argentina;Brazil;Bulgaria;Chile;Czechia;Germany;Italy;Korea, Republic of;Mexico;Peru;P ...
4	EUCTR2013-002758-62-ES (EUCTR)	16/07/2014	21/07/2014	Long-term safety and tolerability study of ataciceptin patients with Systemic Lupus Erythematosus wh ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.0;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	213	Phase 2	United States;Philippines;Spain;Ukraine;Russian Federation;Chile;United Kingdom;Italy;Czech Republic ...
5	EUCTR2013-002758-62-CZ (EUCTR)	19/06/2014	16/04/2014	Long-term safety and tolerability study of ataciceptin patients with Systemic Lupus Erythematosus wh ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 19.0;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	213	Phase 2	United States;Philippines;Spain;Ukraine;Chile;Russian Federation;United Kingdom;Italy;Czech Republic ...
6	EUCTR2013-002758-62-GB (EUCTR)	09/05/2014	13/05/2014	Long-term safety and tolerability study of ataciceptin patients with Systemic Lupus Erythematosus wh ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.0;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	213	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Philippines;Spain;Ukraine;Russian Federation;Chile;United Kingdom;Italy;Czech Republic ...
7	EUCTR2013-002758-62-BG (EUCTR)	30/04/2014	01/04/2014	Long-term safety and tolerability study of ataciceptin patients with Systemic Lupus Erythematosus wh ...	A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 18.0;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	213	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Philippines;Spain;Ukraine;Russian Federation;Chile;United Kingdom;Italy;Czech Republic ...
8	EUCTR2013-002773-21-IT (EUCTR)	25/03/2014	03/02/2014	Efficacy and safety study of atacicept in patients with Systemic Lupus Erythematosus (ADDRESS II)	A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	279	Phase 2	United States;Philippines;Spain;Ukraine;Chile;Russian Federation;United Kingdom;Italy;Czech Republic ...
9	EUCTR2013-002773-21-GB (EUCTR)	03/03/2014	15/01/2014	Efficacy and safety study of atacicept in patients with Systemic Lupus Erythematosus (ADDRESS II)	A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.0;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	279	Phase 2	United States;Philippines;Spain;Ukraine;Russian Federation;Chile;United Kingdom;Italy;Czech Republic ...
10	EUCTR2013-002773-21-ES (EUCTR)	20/02/2014	22/01/2014	Efficacy and safety study of atacicept in patients with Systemic Lupus Erythematosus (ADDRESS II)	A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Atacicept INN or Proposed INN: Atacicept Other descriptive name: ATACICEPT Product Name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	279	Phase 2	United States;Philippines;Spain;Ukraine;Chile;Russian Federation;United Kingdom;Italy;Czech Republic ...

First Previous1 2 3Next Last